PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026Cell Reports2 citationsOpen Access

NAD+ sensing by PARP7 regulates the C/EBPβ-dependent transcription program during adipogenesis

View Full Paper
MSMiKayla S StokesYKYoon Jung KimYKYonghyeon Kim

Key Points

  • PARP7 regulates C/EBPβ-dependent transcription essential for adipogenesis, impacting body weight regulation.
  • A decline in nuclear NAD+ concentrations during differentiation leads to reduced auto-marylation of PARP7, influencing its stability.
  • Laboratory analysis indicates the E3 ligase-ubiquitin-proteasome pathway mediates PARP7 degradation by ubiquitylating MARylated proteins.
  • Findings may enable new approaches to control adipogenesis and related metabolic conditions, emphasizing PARP7's role.

Abstract

We identified poly(ADP-ribose) polymerase 7 (PARP7), a mono(ADP-ribosyl) transferase, as a regulator of C/EBPβ-dependent proadipogenic gene expression. PARP7 functions as a nuclear NAD+ sensor; at higher nuclear NAD+ concentrations in undifferentiated preadipocytes, PARP7 is catalytically active for auto-mono(ADP-ribosyl)ation (autoMARylation). As nuclear NAD+ concentrations decline upon differentiation, autoMARylation decreases dramatically. AutoMARylation promotes instability of PARP7 through an E3 ligase-ubiquitin-proteasome pathway mediated by the ubiquitin E3 ligases DTX2 and RNF114, which ubiquitylate MARylated PARP7. Stabilized PARP7 serves as a coregulator of C/EBPβ by stimulating p300-mediated histone H3 lysine 27 acetylation and the binding of C/EBPβ across the genome. Genetic depletion of PARP7 in mice promotes decreased body weight in mice fed a high-fat diet, reduced fat mass, inhibition of adipogenesis during mammary gland involution, and a reduction in lipid synthesis. Collectively, our results extend the biology of PARP7 to adipogenesis and elucidate the molecular mechanisms underlying a PARP7-p300-H3K27ac-C/EBPβ pathway for proadipogenic gene regulation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Stokes et al. (2026) studied this question.

synapsesocial.com/papers/69a75f71c6e9836116a2ad23https://doi.org/10.1016/j.celrep.2026.116929
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Identification of the Aryl Hydrocarbon Receptor Target Gene TiPARP as a Mediator of Suppression of Hepatic Gluconeogenesis by 2,3,7,8-Tetrachlorodibenzo-p-dioxin and of Nicotinamide as a Corrective Agent for This Effect2010 · 122 citations
  2. 2The complex network of p300/CBP regulation: Interactions, posttranslational modifications, and therapeutic implications2025 · 30 citations
  3. 3A conditional knockout resource for the genome-wide study of mouse gene function2011 · 1,844 citations
  4. 4Differential binding of NAD + and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor2003 · 333 citations
  5. 5The rise of ADP-ribose–ubiquitin2025 · 11 citations